Olga P. Dribnokhodova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Olga P. Dribnokhodova has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- Konstantin Olegovich Mironov
Central Research Institute of Epidemiology
10 shared publications - German A. Shipulin
Centre for Strategic Planning and Management of Biomedical Health Risks
6 shared publications - Vitaly I. Korchagin
Laboratory of Genome Organization, Institute of Gene Biology of the Russian Academy of Sciences, 119334 Moscow, Russia
6 shared publications - Alexander E. Platonov
Central Research Institute of Epidemiology
4 shared publications - Anton A. Raskurazhev
Research Center of Neurology
2 shared publications E A Dunaeva
2 shared publications
Latest Publications
- Open Access
- 15 December 2024
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 79 (6) , 481-489
The set of PCR-based laboratory methods for molecular diagnostics in oncology
The development of accessible and sensitive methods for mutations analysis leading to tumor and for evaluation of patients’ individual genetic characteristics is essential for molecular genetic studies both in clinical and epidemiological research. The Central Research Institute of Epidemiology has developed a set of techniques for the qualitative detection of germinal mutations and single nucleotide polymorphisms, as well as for the quantification of the mutant alleles of somatic mutations using pyrosequencing and real-time PCR. The methods allow identifying the most common mutations in the Russian Federation in the BRCA1, BRCA2, NBN, and CHEK2 genes, responsible for hereditary tumor syndromes, and polymorphisms in the TTC34, MIR146A, CYP1A1, MICA, PAX8, MTHFR, HLA-DQB1, and HLA-DQA1 genes associated with an increased risk of cervical cancer, and in genes involved in drug biotransformation. Quantitative methods are designed to determine somatic mutations in the BRAF, KRAS, HRAS, NRAS, JAK2, MPL and CALR genes in the solid tumors and in hematology. The developed set of scientific and diagnostic techniques is being employed for analysis of genetic polymorphisms and mutations in Russian population. Some of the techniques are available as reagent kits and are used in practice.
- 15 December 2024
- Published by Paediatrician Publishers LLC in Annals of the Russian academy of medical sciences
- Vol. 79 (6) , 481-489
Open AccessThe set of PCR-based laboratory methods for molecular diagnostics in oncology
The development of accessible and sensitive methods for mutations analysis leading to tumor and for evaluation of patients’ individual genetic characteristics is essential for molecular genetic studies both in clinical and epidemiological research. The Central Research Institute of Epidemiology has developed a set of techniques for the qualitative detection of germinal mutations and single nucleotide polymorphisms, as well as for the quantification of the mutant alleles of somatic mutations using pyrosequencing and real-time PCR. The methods allow identifying the most common mutations in the Russian Federation in the BRCA1, BRCA2, NBN, and CHEK2 genes, responsible for hereditary tumor syndromes, and polymorphisms in the TTC34, MIR146A, CYP1A1, MICA, PAX8, MTHFR, HLA-DQB1, and HLA-DQA1 genes associated with an increased risk of cervical cancer, and in genes involved in drug biotransformation. Quantitative methods are designed to determine somatic mutations in the BRAF, KRAS, HRAS, NRAS, JAK2, MPL and CALR genes in the solid tumors and in hematology. The developed set of scientific and diagnostic techniques is being employed for analysis of genetic polymorphisms and mutations in Russian population. Some of the techniques are available as reagent kits and are used in practice.
- Open Access
- 22 October 2024
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 6,p. 14-19
Association between rs8192678 C/T polymorphism of the PPARGC1A gene and metabolically associated fatty liver disease in obese children living in the Moscow region
Over the past 30 years, the incidence of childhood obesity has quadrupled, leading to a rise in metabolically associated fatty liver disease (MAFLD), which has multifactorial genesis. Numerous studies highlight a significant genetic contribution to the development and severity of MAFLD. Purpose of the study. Тo determine the distribution of alleles and genotypes of the rs8192678 C/T polymorphism of the PPARGC1A gene and its relationship with the development of MAFLD in obese children living in the Moscow region. Materials and methods. The study included 87 children with exogenous constitutional obesity. The children were divided into two groups: group I - obesity without MAFLD (n = 43), group II - obesity with MAFLD (n = 44). The association of genotypes with the risk of developing MAFLD was studied in various genetic models. Results. 43 (49.4%) children had genotypes containing the T allele: 4 (4.6%) - homozygous TT genotype, 39 (44.8%) - heterozygous CT genotype. The CC genotype was detected in 44 (50.6%) children. The frequency of allele C was 73%. Carriers of the T allele have almost twice the risk of developing MAFLD than сarriers of the C allele (OR = 2.08 (95% CI: 1.05-4.24), p = 0.041). Conclusion. Тhe rs8192678 polymorphism increases the risk of developing MAFLD already in childhood, and with the homozygous TT genotype, this risk more than doubles. Studying the genetic contribution to the development of MAFLD enables a comprehensive approach to assessing individual risks of each patient.
- 22 October 2024
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 6,p. 14-19
Open AccessAssociation between rs8192678 C/T polymorphism of the PPARGC1A gene and metabolically associated fatty liver disease in obese children living in the Moscow region
Over the past 30 years, the incidence of childhood obesity has quadrupled, leading to a rise in metabolically associated fatty liver disease (MAFLD), which has multifactorial genesis. Numerous studies highlight a significant genetic contribution to the development and severity of MAFLD. Purpose of the study. Тo determine the distribution of alleles and genotypes of the rs8192678 C/T polymorphism of the PPARGC1A gene and its relationship with the development of MAFLD in obese children living in the Moscow region. Materials and methods. The study included 87 children with exogenous constitutional obesity. The children were divided into two groups: group I - obesity without MAFLD (n = 43), group II - obesity with MAFLD (n = 44). The association of genotypes with the risk of developing MAFLD was studied in various genetic models. Results. 43 (49.4%) children had genotypes containing the T allele: 4 (4.6%) - homozygous TT genotype, 39 (44.8%) - heterozygous CT genotype. The CC genotype was detected in 44 (50.6%) children. The frequency of allele C was 73%. Carriers of the T allele have almost twice the risk of developing MAFLD than сarriers of the C allele (OR = 2.08 (95% CI: 1.05-4.24), p = 0.041). Conclusion. Тhe rs8192678 polymorphism increases the risk of developing MAFLD already in childhood, and with the homozygous TT genotype, this risk more than doubles. Studying the genetic contribution to the development of MAFLD enables a comprehensive approach to assessing individual risks of each patient.
- Open Access
- 28 April 2022
- Published by Journal Sovremennye Tehnologii v Medicine in Sovremennye tehnologii v medicine
- Vol. 14 (2) , 41-49
A Complex of Pyrosequencing-Based Methods for Detection of Somatic Mutations in Codons 600 and 601 of the BRAF Gene
The aim of the study is to develop methods for the differentiation of mutations in the BRAF codon 600 and to increase the sensitivity of the K601E mutation detection. Materials and Methods. The nucleotide sequence of the BRAF codons 592-602 was identified using the PyroMark Q24 genetic analysis system. The mutations search in codon 600 was conducted using the 600-S primer in line with the following order of adding nucleotides: GCTGTCATCTGCTAGCTAGAC (corresponding to nucleotides 1799-1786). The K601E mutation was detected using the 601-S primer in line with the following order of nucleotide addition: GCTACTCACTGTAG (corresponding to nucleotides 1801-1793). The analytical characteristics of the proposed methods for somatic mutations' detection were determined using dilutions of plasmid DNA samples containing the BRAF gene region without mutations or with one of the following mutations: V600E, V600R, V600K, V600M, and K601E. Validation was performed on 132 samples of biological material obtained from the thyroid nodules. Results. The developed methods allow to determine 2% of the V600E or V600M mutations, 1% of the V600K and V600R mutations, and 3% of the K601E mutations in samples with high DNA concentration; it is also possible to confidently detect at least 5% of the mutant allele for all mutations in low concentration samples (less than 500 copies/PCR). During biological material testing, 53 samples with the V600E mutation were detected; the proportion of the mutant allele was 4.9-50.0%. Conclusion. A complex of methods for determination of the nucleotide sequence of the BRAF codons 592-601 and the algorithm for testing samples and analyzing mutations in the BRAF codons 600-601 was developed. The method provides sufficient sensitivity to detect frequent mutations in codons 600 and 601 and allows them to be precisely differentiated.
- 28 April 2022
- Published by Journal Sovremennye Tehnologii v Medicine in Sovremennye tehnologii v medicine
- Vol. 14 (2) , 41-49
Open AccessA Complex of Pyrosequencing-Based Methods for Detection of Somatic Mutations in Codons 600 and 601 of the BRAF Gene
The aim of the study is to develop methods for the differentiation of mutations in the BRAF codon 600 and to increase the sensitivity of the K601E mutation detection. Materials and Methods. The nucleotide sequence of the BRAF codons 592-602 was identified using the PyroMark Q24 genetic analysis system. The mutations search in codon 600 was conducted using the 600-S primer in line with the following order of adding nucleotides: GCTGTCATCTGCTAGCTAGAC (corresponding to nucleotides 1799-1786). The K601E mutation was detected using the 601-S primer in line with the following order of nucleotide addition: GCTACTCACTGTAG (corresponding to nucleotides 1801-1793). The analytical characteristics of the proposed methods for somatic mutations' detection were determined using dilutions of plasmid DNA samples containing the BRAF gene region without mutations or with one of the following mutations: V600E, V600R, V600K, V600M, and K601E. Validation was performed on 132 samples of biological material obtained from the thyroid nodules. Results. The developed methods allow to determine 2% of the V600E or V600M mutations, 1% of the V600K and V600R mutations, and 3% of the K601E mutations in samples with high DNA concentration; it is also possible to confidently detect at least 5% of the mutant allele for all mutations in low concentration samples (less than 500 copies/PCR). During biological material testing, 53 samples with the V600E mutation were detected; the proportion of the mutant allele was 4.9-50.0%. Conclusion. A complex of methods for determination of the nucleotide sequence of the BRAF codons 592-601 and the algorithm for testing samples and analyzing mutations in the BRAF codons 600-601 was developed. The method provides sufficient sensitivity to detect frequent mutations in codons 600 and 601 and allows them to be precisely differentiated.
- Open Access
- 31 October 2021
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 20 (5) , 75-83-83
DETECTION OF SOMATIC MUTATIONS IN THE BRAF GENE BY PYROSEQUENCING
Introduction. Detection of somatic mutations in the BRAF gene can be used in clinical oncology to clarify the diagnosis, select therapy and assess the prognosis of the disease. Pyrosequencing technology makes it possible to identify both already known and new mutations, as well as to determine the mutant allele ratio in the sample.The aim of the study was to develop the pyrosequencing-based method for detecting mutations in 592–601 codons of the BRAF gene.Material and Methods. The nucleotide sequences were obtained using «PyroMark Q24» instrument. The sensitivity and specificity of the method were estimated using dilutions of plasmid DNA samples containing the intact BRAF gene fragment mixed with sequence containing one of the mutations V600E, V600R, V600K, V600M, and K601E. The clinical testing was performed on 200 samples from thyroid nodules.Results. The developed method makes it possible to determine samples containing 2 % of the mutant allele for mutations V600K and V600R, 3 % for V600E and V600M, and 10 % for K601E. The pyrogram signal values for samples without mutations ranged from 0 to 19.5 % for different mutations. An analysis algorithm was developed to confirm the presence and differentiation of mutations in the 600 codon at a low proportion of the mutant allele based on the signals ratio on the pyrogram. The 47 clinical samples with mutations were found, 45 with V600E and 1 with V600_K601>E, for one sample, the type of mutation in the 600 codon could not be determined. The proportion of the mutant allele was 3.5–45 %. The concentration of extracted DNA less than 10 copies per mkl was obtained in 47 samples, of which 8 samples were found to have the mutations.Conclusion. The pyrosequencing-based method was developed for the detection of somatic mutations in 592–601 codons of the BRAF gene. The technique provided sufficient sensitivity to detect frequent mutations in the 600 codon and allowed the detection of rare mutations. Extraction of DNA from clinical samples obtained by fine-needle aspiration biopsy in most cases provided a sufficient concentration of DNA, which made it possible to use the technique in combination with cytological analysis without additional sampling. This approach can be applied to determine somatic mutations in DNA fragments of same length for other oncogenes.
- 31 October 2021
- Published by Tomsk Cancer Research Institute in Siberian journal of oncology
- Vol. 20 (5) , 75-83-83
Open AccessDETECTION OF SOMATIC MUTATIONS IN THE BRAF GENE BY PYROSEQUENCING
Introduction. Detection of somatic mutations in the BRAF gene can be used in clinical oncology to clarify the diagnosis, select therapy and assess the prognosis of the disease. Pyrosequencing technology makes it possible to identify both already known and new mutations, as well as to determine the mutant allele ratio in the sample.The aim of the study was to develop the pyrosequencing-based method for detecting mutations in 592–601 codons of the BRAF gene.Material and Methods. The nucleotide sequences were obtained using «PyroMark Q24» instrument. The sensitivity and specificity of the method were estimated using dilutions of plasmid DNA samples containing the intact BRAF gene fragment mixed with sequence containing one of the mutations V600E, V600R, V600K, V600M, and K601E. The clinical testing was performed on 200 samples from thyroid nodules.Results. The developed method makes it possible to determine samples containing 2 % of the mutant allele for mutations V600K and V600R, 3 % for V600E and V600M, and 10 % for K601E. The pyrogram signal values for samples without mutations ranged from 0 to 19.5 % for different mutations. An analysis algorithm was developed to confirm the presence and differentiation of mutations in the 600 codon at a low proportion of the mutant allele based on the signals ratio on the pyrogram. The 47 clinical samples with mutations were found, 45 with V600E and 1 with V600_K601>E, for one sample, the type of mutation in the 600 codon could not be determined. The proportion of the mutant allele was 3.5–45 %. The concentration of extracted DNA less than 10 copies per mkl was obtained in 47 samples, of which 8 samples were found to have the mutations.Conclusion. The pyrosequencing-based method was developed for the detection of somatic mutations in 592–601 codons of the BRAF gene. The technique provided sufficient sensitivity to detect frequent mutations in the 600 codon and allowed the detection of rare mutations. Extraction of DNA from clinical samples obtained by fine-needle aspiration biopsy in most cases provided a sufficient concentration of DNA, which made it possible to use the technique in combination with cytological analysis without additional sampling. This approach can be applied to determine somatic mutations in DNA fragments of same length for other oncogenes.
- 6 January 2021
- Published by Taylor & Francis in Epigenomics
- Vol. 13 (4) , 285-297
Aging-Induced Changes in Sperm DNA Methylation are Modified by Low Dose of Perinatal Flame Retardants
Aims: Paternal age is increasing in developed countries. Understanding of aging-related epigenetic changes in sperm is needed as well as factors that modify such changes. Materials & methods: Young...
- 6 January 2021
- Published by Taylor & Francis in Epigenomics
- Vol. 13 (4) , 285-297
Aging-Induced Changes in Sperm DNA Methylation are Modified by Low Dose of Perinatal Flame Retardants
Aims: Paternal age is increasing in developed countries. Understanding of aging-related epigenetic changes in sperm is needed as well as factors that modify such changes. Materials & methods: Young...
- 5 October 2020
- Published by Central Research Institute for Epidemiology
CLINICAL TRIALS OF THE DIAGNOSTIC SYSTEM FOR THE ANALYSIS OF GENETIC RISKS OF CARDIOEMBOLIC AND ATHEROTROMBOTIC SUBTYPES OF ISCHEMIC STROKE
A clinical trial of the diagnostic kit for analysis of the genetic predisposition to ischemic stroke was carried out on an 767 independent blood samples. Genetic risk’s values of ischemic stroke were determined in the groups of patients and control, and its distribution between 6 groups of SNP combinations was analyzed in accordance with the suggested model. The differences by genetic risk values between the patient’s samples and the control group were determined as statistically significant (p
- 5 October 2020
- Published by Central Research Institute for Epidemiology
CLINICAL TRIALS OF THE DIAGNOSTIC SYSTEM FOR THE ANALYSIS OF GENETIC RISKS OF CARDIOEMBOLIC AND ATHEROTROMBOTIC SUBTYPES OF ISCHEMIC STROKE
A clinical trial of the diagnostic kit for analysis of the genetic predisposition to ischemic stroke was carried out on an 767 independent blood samples. Genetic risk’s values of ischemic stroke were determined in the groups of patients and control, and its distribution between 6 groups of SNP combinations was analyzed in accordance with the suggested model. The differences by genetic risk values between the patient’s samples and the control group were determined as statistically significant (p
- 1 December 2017
- Published by Pleiades Publishing Ltd in Human Physiology
- Vol. 43 (8) , 886-897
The Role of Genetic Factors in the Development of Individual Predisposition to Ischemic Stroke
Intensive development of DNA analysis technologies and large-scale genome-wide association studies have led to accumulation of a large array of data on the relationship between genetic factors and various phenotypic manifestations, including monogenic and polygenic hereditary diseases. This has greatly extended the capabilities of clinical diagnostics and predictive medicine in the field of socially significant diseases. For example, the role of a genetic component of the risk for such multifactorial and polyetiologic disease as stroke is now actively explored. Large-scale studies have revealed both general and specific genetic markers associated only with a certain type and subtype of stroke. This review analyzes the current state of the problem of using genetic markers for diagnosis of predisposition to stroke, complex issues associated with multiplicity of risk factors for stroke, and potential development in this area.
- 1 December 2017
- Published by Pleiades Publishing Ltd in Human Physiology
- Vol. 43 (8) , 886-897
The Role of Genetic Factors in the Development of Individual Predisposition to Ischemic Stroke
Intensive development of DNA analysis technologies and large-scale genome-wide association studies have led to accumulation of a large array of data on the relationship between genetic factors and various phenotypic manifestations, including monogenic and polygenic hereditary diseases. This has greatly extended the capabilities of clinical diagnostics and predictive medicine in the field of socially significant diseases. For example, the role of a genetic component of the risk for such multifactorial and polyetiologic disease as stroke is now actively explored. Large-scale studies have revealed both general and specific genetic markers associated only with a certain type and subtype of stroke. This review analyzes the current state of the problem of using genetic markers for diagnosis of predisposition to stroke, complex issues associated with multiplicity of risk factors for stroke, and potential development in this area.
- 1 June 2017
- Published by Pleiades Publishing Ltd in Russian Journal of Genetics
- Vol. 53 (6) , 698-702
Characterization of 48 polymorphic loci as potential markers for the risk of ischemic stroke
With the aim to determine specific genetic characteristics of the population of Moscow region, we determined allele frequencies of 48 polymorphic loci (SNP) associated with the increased risk of ischemic stroke development. The genotype frequency distribution for all the SNPs corresponds to Hardy–Weinberg equilibrium. Comparison of the allele frequencies with those obtained for Caucasian populations from the databases dbSNP and 1000 Genomes Project revealed significant differences for two SNPs (rs556621 and rs556512) and seven SNPs (rs556621, rs556512, rs1801133, rs1799983, rs5918, rs328, and rs2398162), respectively. The revealed genetic features of the population make it possible to increase the accuracy and reliability of the individual genetic risk assessment of development for multifactorial diseases in the examined population.
- 1 June 2017
- Published by Pleiades Publishing Ltd in Russian Journal of Genetics
- Vol. 53 (6) , 698-702
Characterization of 48 polymorphic loci as potential markers for the risk of ischemic stroke
With the aim to determine specific genetic characteristics of the population of Moscow region, we determined allele frequencies of 48 polymorphic loci (SNP) associated with the increased risk of ischemic stroke development. The genotype frequency distribution for all the SNPs corresponds to Hardy–Weinberg equilibrium. Comparison of the allele frequencies with those obtained for Caucasian populations from the databases dbSNP and 1000 Genomes Project revealed significant differences for two SNPs (rs556621 and rs556512) and seven SNPs (rs556621, rs556512, rs1801133, rs1799983, rs5918, rs328, and rs2398162), respectively. The revealed genetic features of the population make it possible to increase the accuracy and reliability of the individual genetic risk assessment of development for multifactorial diseases in the examined population.
- 1 January 2017
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 117 (12) , 11-18
Complex assessment of the contribution of genetic factors to the risk of ischemic stroke
- 1 January 2017
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 117 (12) , 11-18
Complex assessment of the contribution of genetic factors to the risk of ischemic stroke
- 31 March 2015
- No. 6,p. 35-42
[A method for determination of Neisseria meningitidis serogroup A, B, C and W by real-time PCR].
Development and testing of a real-time PCR method for detection of Neisseria meningitiis serogroup A, B, C and W DNA. Reference strains and 187 samples of cerebrospinal fluid (CSF) from meningocci meningitis patients were used in the study. Multiplex PCR was carried out in an instrument with 5 channels of fluorescent detection: Analysis of specific serogroup loci of the genome and design of oligonucleotides for the detection of DNA of all the capsule meningococci and 4 serogroups in particular was carried out. PCR conditions were optimized; specificity was shown and analytical sensitivity was evaluated using reference strains. DNA of the following serogroups was detected during study of clinical CSF samples: A--in 103 samples (55%), B--in 45 (24%), C--in 30 (16%), W--in 5 (3%). Only DNA of meningococci capstle gene ctrA was found in 4 samples; presumably, they contained DNA of other serogroups. Multilocus sequence-typing and detection of antigenic determinants of PorA and FetA genes for 27 DNA samples of group A menincococci as well as DNA of 5 group W meningococci and 4 ungroupable was carried out. The method proposed allows to carry out serogrouping of no less than 95% of strains or DNA samples isolated from CSF of meningococci infection patients. Combined with other recommended non-cultural methods of genotyping, it may be useful for complex characteristics of pathogenic meningococci.
- 31 March 2015
- No. 6,p. 35-42
[A method for determination of Neisseria meningitidis serogroup A, B, C and W by real-time PCR].
Development and testing of a real-time PCR method for detection of Neisseria meningitiis serogroup A, B, C and W DNA. Reference strains and 187 samples of cerebrospinal fluid (CSF) from meningocci meningitis patients were used in the study. Multiplex PCR was carried out in an instrument with 5 channels of fluorescent detection: Analysis of specific serogroup loci of the genome and design of oligonucleotides for the detection of DNA of all the capsule meningococci and 4 serogroups in particular was carried out. PCR conditions were optimized; specificity was shown and analytical sensitivity was evaluated using reference strains. DNA of the following serogroups was detected during study of clinical CSF samples: A--in 103 samples (55%), B--in 45 (24%), C--in 30 (16%), W--in 5 (3%). Only DNA of meningococci capstle gene ctrA was found in 4 samples; presumably, they contained DNA of other serogroups. Multilocus sequence-typing and detection of antigenic determinants of PorA and FetA genes for 27 DNA samples of group A menincococci as well as DNA of 5 group W meningococci and 4 ungroupable was carried out. The method proposed allows to carry out serogrouping of no less than 95% of strains or DNA samples isolated from CSF of meningococci infection patients. Combined with other recommended non-cultural methods of genotyping, it may be useful for complex characteristics of pathogenic meningococci.